Dennis Purcell
Managing Director · Aisling Capital
Dennis Purcell, founder and senior advisor of Aisling Capital, invests primarily in **early-stage biopharmaceutical and life science companies**, focusing on sectors like genomically defined cancers, therapeutics, and clinical outsourcing services[2][6][12]. His firm’s distinctive thesis requires **clinical trial data, reasonable valuations, and a 3–5-year exit horizon** before entering a deal[7]…
- Stages: Pre-Seed, Seed
- Location: New York, New York, United States
Website
Browse all investors · Browse founders